Skip to main content
FinSpry Logo
FinSpry
UTHR logo
UTHR
(NASDAQ)
United Therapeutics Corporation
$564.81-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

United Therapeutics (UTHR) Stock Price & Financial Analysis

United Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$551.30 - $577.86
52-Week High$607.89
52-Week Low$266.98
Open$565.00
Volume801.73K
Average Volume (3M)801.73K
Market Cap27.05B
Shares Outstanding47.90M
P/E Ratio (TTM)20.47
Forward P/E18.33
Price to Sales (P/S)8.58
Price to Book (P/B)3.85
EV/EBITDA13.75
Revenue (TTM)3.18B
Net Income (TTM)1.33B
Free Cash Flow (TTM)1.04B
EPS (TTM)$27.86
Profit Margin41.94%
Operating Margin47.60%
Return on Equity (ROE)18.81%
Debt to Equity0.00
50-Day MA$502.85
200-Day MA$425.77
52-Week Change85.83%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About United Therapeutics

What is the current stock price for UTHR?

As of the latest trading session, UTHR stock trades at $564.81. The 52-week range is $266.98–$607.89, with a day range of $551.30–$577.86.

What is the P/E ratio for UTHR?

United Therapeutics's trailing P/E ratio is 20.5, meaning investors pay $20.5 for every $1 of annual earnings. The forward P/E is 18.3, reflecting analyst expectations for future earnings. United Therapeutics operates in the Healthcare sector.

Does UTHR pay dividends?

United Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for UTHR?

Based on 8 analysts, the consensus for UTHR is Strong Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of UTHR?

United Therapeutics's market capitalization is $27.05B, classifying it as a large-cap company. United Therapeutics operates in the Healthcare sector within the Drug Manufacturers - Specialty & Generic industry.